Association of telomere length with authentic pluripotency of ES/iPS cells

Cell Research

Volumn 21, Issue 5, 2011, Pages 779-792

  Huang, Junjiu ^a,b   Wang, Fang ^a,c   Okuka, Maja ^b   Liu, Na ^c   Ji, Guangzhen ^c   Ye, Xiaoying ^c   Zuo, Bingfeng ^c   Li, Minshu ^c   Liang, Ping ^d   Ge, William W ^e   Tsibris, John Cm ^b   Keefe, David L ^b,f   Liu, Lin ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NANKAI UNIVERSITY   (China)

^d BROCK UNIVERSITY   (Canada)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ESCs; iPSCs; pluripotency; telomerase; telomere

Indexed keywords

TELOMERASE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; EMBRYONIC STEM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; MOUSE; PATHOLOGY; PLURIPOTENT STEM CELL; TELOMERE; TERATOMA;

ANIMALS; CELL LINE; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; TELOMERASE; TELOMERE; TERATOMA; TRANSCRIPTION, GENETIC;

RODENTIA;

EID: 79955573452     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2011.16     Document Type: Article

References (54)

1. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008; 132:567-582. (Pubitemid 351253686)
2. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009; 136:509-523.
3. Silva J, Smith A. Capturing pluripotency. Cell 2008; 132:532-536. (Pubitemid 351253697)
4. Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008; 132:1049-1061. (Pubitemid 351381745)
5. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 1993; 90:8424-8428. (Pubitemid 23277681)
6. Zhao XY, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009; 461:86-90.
7. Eggan K, Rode A, Jentsch I, et al. Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation. Nat Biotechnol 2002; 20:455-459. (Pubitemid 34495930)
8. Poueymirou WT, Auerbach W, Frendewey D, et al. F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat Biotechnol 2007; 25:91-99. (Pubitemid 46091512)
9. Huang J, Deng K, Wu H, et al. Efficient production of mice from embryonic stem cells injected into four- or eight-cell embryos by piezo micromanipulation. Stem Cells 2008; 26:1883-1890.
10. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106:661-673. (Pubitemid 32900658)
11. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42:301-334.
12. Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91:25-34. (Pubitemid 27431310)
13. Lee HW, Blasco MA, Gottlieb GJ, et al. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392:569-574. (Pubitemid 28207706)
14. Herrera E, Samper E, Martin-Caballero J, et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 1999; 18:2950-2960. (Pubitemid 29255604)
15. Hiyama E, Hiyama K. Telomere and telomerase in stem cells. Br J Cancer 2007; 96:1020-1024. (Pubitemid 46608315)
16. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
17. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. Defin- ing molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008; 2:230-240.
18. Niida H, Shinkai Y, Hande MP, et al. Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol Cell Biol 2000; 20:4115-4127. (Pubitemid 30314509)
19. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6:611-622.
20. Allsopp RC, Chang E, Kashefi-Aazam M, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995; 220:194-200.
21. Marion RM, Strati K, Li H, et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009; 4:141-154.
22. Agarwal S, Loh YH, McLoughlin EM, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010; 464:292-296.
23. Marion RM, Blasco MA. Telomere rejuvenation during nuclear reprogramming. Curr Opin Genet Dev 2010; 20:190-196.
24. Vaziri H, Chapman KB, Guigova A, et al. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regen Med 2010; 5:345-363.
25. Zijlmans JM, Martens UM, Poon SS, et al. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci USA 1997; 94:7423-7428. (Pubitemid 27345331)
26. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996; 5:207-216. (Pubitemid 26341364)
27. Wang Y, Erdmann N, Giannone RJ, et al. An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres. Proc Natl Acad Sci USA 2005; 102:10256-10260. (Pubitemid 41023359)
28. Flores I, Cayuela ML, Blasco MA. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005; 309:1253-1256. (Pubitemid 41170921)
29. Baudino TA, McKay C, Pendeville-Samain H, et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002; 16:2530-2543.
30. Blum B, Bar-Nur O, Golan-Lev T, Benvenisty N. The antiapoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 2009; 27:281-287.
31. Gertow K, Przyborski S, Loring JF, et al. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol 2007; 3:1B.4.1-1-B.4.29.
32. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
33. Ohnuki M, Takahashi K, Yamanaka S. Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol 2009; 9:4A.2.1-4A.2.25.
34. Muller FJ, Goldmann J, Loser P, Loring JF. A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 2010; 6:412-414.
35. Daley GQ, Lensch MW, Jaenisch R, et al. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 2009; 4:200-201; author reply 202.
36. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-460.
37. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99:247-257. (Pubitemid 29519904)
38. Brooks WS, Helton ES, Banerjee S, et al. G2E3 is a dual function ubiquitin ligase required for early embryonic development. J Biol Chem 2008; 283:22304-22315.
39. Lefebvre L, Viville S, Barton SC, et al. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat Genet 1998; 20:163-169. (Pubitemid 28455449)
40. Gonzalo S, Jaco I, Fraga MF, et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 2006; 8:416-424.
41. Benetti R, Gonzalo S, Jaco I, et al. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J Cell Biol 2007; 178:925-936. (Pubitemid 47443317)
42. Zalzman M, Falco G, Sharova LV, et al. Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 2010; 464:858-863.
43. Ivanova N, Dobrin R, Lu R, et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006; 442:533-538. (Pubitemid 44167907)
44. Hayashi K, de Sousa Lopes SM, Surani MA. Germ cell specification in mice. Science 2007; 316:394-396. (Pubitemid 46651475)
45. Liu L, Bailey SM, Okuka M, et al. Telomere lengthening early in development. Nat Cell Biol 2007; 9:1436-1441. (Pubitemid 350201757)
46. Hao LY, Armanios M, Strong MA, et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 2005; 123:1121-1131. (Pubitemid 41785425)
47. Hanna J, Saha K, Pando B, et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462:595-601.
48. Yang C, Przyborski S, Cooke MJ, et al. A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 2008; 26:850-863.
49. Chen Z, Liu Z, Huang J, et al. Birth of parthenote mice directly from parthenogenetic embryonic stem cells. Stem Cells 2009; 27:2136-2145.
50. Okita K, Ichisaka T, Yamanaka S. Generation of germlinecompetent induced pluripotent stem cells. Nature 2007; 448:313-317. (Pubitemid 47080336)
51. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47.
52. Callicott RJ, Womack JE. Real-time PCR assay for measurement of mouse telomeres. Comp Med 2006; 56:17-22.
53. O'Callaghan N, Dhillon V, Thomas P, Fenech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques 2008; 44:807-809. (Pubitemid 351839149)
54. Huang J, Okuka M, Wang F, et al. Generation of pluripotent stem cells from eggs of aging mice. Aging Cell 2010; 9:113-125.